
Welcome to
ONLiNE UPSC
The Major’s List is an annual U.S. document naming countries that significantly contribute to the production or transit of narcotics and precursors. Inclusion does not necessarily mean weak enforcement but highlights their role in the international drug trade. India, Pakistan, China, and Afghanistan figure prominently because of their links to precursor supply chains.
Fentanyl is a synthetic opioid, medically used for severe pain but illicitly abused for its extreme potency—about 50 times stronger than heroin. Just a few milligrams can be fatal. It is the leading cause of drug overdose deaths in the U.S., with over 57,000 deaths reported in one year (2023–2024).
Fentanyl binds to opioid receptors in the brain, dulling pain but also suppressing breathing and heart functions. Overdose can cause respiratory failure, brain damage, and death within minutes. Its high potency makes accidental overdosing very common.
Unlike plant-derived narcotics, fentanyl is made in labs using precursor chemicals. These chemicals—like N-phenethyl-4-piperidone (NPP) and 4-anilino-N-phenethylpiperidine (4-ANPP)—have legitimate industrial and pharmaceutical uses, making strict regulation difficult. Only small amounts of precursors are needed to produce large quantities of fentanyl, and they are easy to transport discreetly.
India has a large pharmaceutical industry and legally produces several chemicals that can serve as precursors for fentanyl. While much production is legitimate, weak monitoring and diversion risks exist. India has tightened regulations, requiring licensing for fentanyl precursors, but U.S. agencies remain watchful. Smugglers often route precursors through India, China, and other hubs before they reach illegal labs, especially in Mexico, where fentanyl is synthesized and trafficked to the U.S.
India’s role as a producer of pharmaceutical precursors makes it vulnerable to diversion into illegal supply chains.
NPP and 4-ANPP are the most important fentanyl precursors, both produced for legitimate industry but misused in drug labs.
By strengthening licensing rules, monitoring exports, and cooperating with the U.S. Drug Enforcement Administration (DEA) and UN drug-control bodies.
China is often accused of being the primary source of illicit precursor exports, while India’s involvement is mostly due to diversion risks from its large pharmaceutical sector.
No, because precursors have legitimate medical and industrial uses. The solution lies in stricter monitoring, licensing, and global cooperation.
Kutos : AI Assistant!